Monopar Therapeutics Inc. (MNPR)

Monopar Therapeutics Statistics

Total Valuation

MNPR has a market cap or net worth of $100.28 million. The enterprise value is $94.26 million.

Market Cap	100.28M
Enterprise Value	94.26M

Important Dates

The last earnings date was Friday, November 8, 2024, before market open.

Earnings Date	Nov 8, 2024
Ex-Dividend Date	n/a

Share Statistics

MNPR has 5.28 million shares outstanding. The number of shares has increased by 23.15% in one year.

Current Share Class	5.28M
Shares Outstanding	5.28M
Shares Change (YoY)	+23.15%
Shares Change (QoQ)	+0.50%
Owned by Insiders (%)	7.87%
Owned by Institutions (%)	14.82%
Float	2.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	13.54
P/TBV Ratio	20.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.41

Current Ratio	5.41
Quick Ratio	5.36
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -112.04% and return on invested capital (ROIC) is -75.69%.

Return on Equity (ROE)	-112.04%
Return on Assets (ROA)	-59.67%
Return on Capital (ROIC)	-75.69%
Revenue Per Employee	n/a
Profits Per Employee	-$647,473
Employee Count	10
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1,166.67% in the last 52 weeks. The beta is 1.10, so MNPR's price volatility has been higher than the market average.

Beta (5Y)	1.10
52-Week Price Change	+1,166.67%
50-Day Moving Average	10.09
200-Day Moving Average	5.05
Relative Strength Index (RSI)	61.89
Average Volume (20 Days)	1,481,973

Short Selling Information

The latest short interest is 72,011, so 1.36% of the outstanding shares have been sold short.

Short Interest	72,011
Short Previous Month	49,852
Short % of Shares Out	1.36%
Short % of Float	3.05%
Short Ratio (days to cover)	0.15

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-7.00M
Pretax Income	-7.12M
Net Income	-6.47M
EBITDA	n/a
EBIT	-7.00M
Earnings Per Share (EPS)	-$1.96

Balance Sheet

Cash & Cash Equivalents	6.02M
Total Debt	n/a
Net Cash	6.02M
Net Cash Per Share	$1.14
Equity (Book Value)	4.95M
Book Value Per Share	1.40
Working Capital	4.95M

Cash Flow

Operating Cash Flow	-5.95M
Capital Expenditures	n/a
Free Cash Flow	-5.95M
FCF Per Share	-$1.13

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MNPR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.15%
Shareholder Yield	-23.15%
Earnings Yield	-6.46%
FCF Yield	-5.94%

Analyst Forecast

The average price target for MNPR is $27.33, which is 43.84% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$27.33
Price Target Difference	43.84%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on August 13, 2024. It was a reverse split with a ratio of 0.2:1.

Last Split Date	Aug 13, 2024
Split Type	Reverse
Split Ratio	0.2:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2